Tulisiak Anne K, Klein Jillian A, Harris Emily, Luft Marissa J, Schroeder Heidi K, Mossman Sarah A, Varney Sara T, Keeshin Brooks R, Cotton Sian, Strawn Jeffrey R
Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati, College of Medicine, Cincinnati, OH.
Department of Pediatrics Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Curr Probl Pediatr Adolesc Health Care. 2017 Jan;47(1):15-24. doi: 10.1016/j.cppeds.2016.11.009. Epub 2017 Jan 2.
Among pediatricians, perceived knowledge of efficacy, tolerability, dosing, and side effects of antidepressants represent significant sources of variability in the use of these medications in youth with depressive and anxiety disorders. Importantly, the qualitative factors that relate to varying levels of comfort with antidepressants and willingness to prescribe are poorly understood. Using a mixed-methods approach, in-depth interviews were conducted with community-based and academic medical center-based pediatricians (N = 14). Interviews were audio recorded and iteratively coded; themes were then generated using inductive thematic analysis. The relationship between demographic factors, knowledge of antidepressants, dosing, and side effects, as well as prescribing likelihood scores for depressive disorders, anxiety disorders or co-morbid anxiety and depressive disorders, were evaluated using mixed models. Pediatricians reported antidepressants to be effective and well-tolerated. However, the likelihood of individual physicians initiating an antidepressant was significantly lower for anxiety disorders relative to depressive disorders with similar functional impairment. Pediatricians considered symptom severity/functional impairment, age and the availability of psychotherapy as they considered prescribing antidepressants to individual patients. Antidepressant choice was related to the physician׳s perceived knowledge and comfort with a particular antidepressant, financial factors, and the disorder-specific evidence base for that particular medication and consultation with mental health practitioners. Pediatricians noted similar efficacy and tolerability profiles for antidepressants in youth with depressive disorders and anxiety disorders, but tended to utilize "therapy first" approaches for anxiety disorders relative to depressive disorders. Parental and family factors that influenced prescribing of antidepressants by pediatricians included parental ambivalence, family-related dysfunction and impairment secondary to the child׳s psychopathology as well as the child׳s psychosocial milieu. Pediatricians consider patient- and family-specific challenges when choosing prescribing antidepressant medications and are, in general, less likely to prescribe antidepressants for youth with anxiety disorders compared to youth with depressive disorders. The lower likelihood of prescribing antidepressants for anxious youth is not related to perception of the efficacy or tolerability, but rather to a perception that anxiety disorders are less impairing and more appropriately managed with psychotherapy.
在儿科医生中,对抗抑郁药疗效、耐受性、剂量和副作用的认知差异是这些药物在患有抑郁和焦虑障碍的青少年中使用存在显著差异的重要原因。重要的是,与对抗抑郁药不同程度的接受度和开药意愿相关的定性因素目前还知之甚少。本研究采用混合方法,对社区和学术医疗中心的儿科医生(N = 14)进行了深入访谈。访谈进行了录音并反复编码;然后采用归纳主题分析法生成主题。使用混合模型评估人口统计学因素、对抗抑郁药的认知、剂量和副作用,以及抑郁障碍、焦虑障碍或共病焦虑和抑郁障碍的开药可能性得分之间的关系。儿科医生报告称抗抑郁药有效且耐受性良好。然而,对于功能损害相似的焦虑障碍患者,个体医生开具抗抑郁药的可能性明显低于抑郁障碍患者。儿科医生在考虑为个体患者开具抗抑郁药时,会考虑症状严重程度/功能损害、年龄和心理治疗的可及性。抗抑郁药的选择与医生对特定抗抑郁药的认知和接受度、经济因素、该特定药物的疾病特异性证据基础以及与心理健康从业者的咨询有关。儿科医生指出,抗抑郁药在患有抑郁障碍和焦虑障碍的青少年中具有相似的疗效和耐受性,但相对于抑郁障碍,他们倾向于对焦虑障碍采用“先治疗”的方法。影响儿科医生开具抗抑郁药的父母和家庭因素包括父母的矛盾情绪、与家庭相关的功能障碍以及因孩子的精神病理学导致的损害,以及孩子的心理社会环境。儿科医生在选择开具抗抑郁药时会考虑患者和家庭的特定挑战,总体而言,与患有抑郁障碍的青少年相比,他们为患有焦虑障碍的青少年开具抗抑郁药的可能性较小。为焦虑青少年开具抗抑郁药的可能性较低并非与对疗效或耐受性的认知有关,而是与认为焦虑障碍损害较小且通过心理治疗能得到更恰当管理的认知有关。